Delivery Order SPE2DB22D9239-SPE2DB25FDL11
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $87,418.08 by the Defense Logistics Agency on July 30, 2025, for the supply of Xenpozyme 20 mg vials. This firm fixed-price delivery order, with an ultimate completion date of August 20, 2025, is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA valued at $499,999,999 and valid through...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $109,272.60 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of XENPOZYME 20 MG VIALS, a specialized pharmaceutical product, with a period of performance through November 6, 2024. DMS Pharmaceutical Group is a key supplier for the DLA, holding a $499,999,999 Indefinite Delivery Contract to...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $37,693.80 by the Defense Logistics Agency's Medical Supply Chain division on August 13, 2025. This firm fixed-price delivery order, with an ultimate completion date of August 14, 2025, carries no set-aside designation and represents performance at the contractor's Park Ridge location. The award leverages DMS Pharmaceutical Group's position...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $23,866.20 by the Defense Logistics Agency's Medical Supply Chain division on July 30, 2025. This delivery order, with an ultimate completion date of July 31, 2025, represents a single issuance under the company's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and extending...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $10,661.78 on August 13, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price delivery order, with an ultimate completion date of September 18, 2025, represents a task order issued under the company's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and...
- The Defense Logistics Agency, through its Medical Supply Chain organization, awarded a firm fixed-price delivery order valued at $46,257.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order, issued on August 13, 2025, with an ultimate completion date of August 14, 2025, carries no set-aside designation. The award falls under DMS Pharmaceutical Group's existing $500 million Indefinite Delivery Contract...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $70,817.80 by the Defense Logistics Agency's Medical Supply Chain division on August 11, 2025. This delivery order, with an ultimate completion date of August 18, 2025, is issued under the company's larger Indefinite Delivery Contract with the DLA valued at $499,999,999 through November 2026. The award carries no set-aside...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $18,488.12 by the Defense Logistics Agency's Medical Supply Chain division on July 24, 2025. This delivery order, which carries an ultimate completion date of July 30, 2025, represents a discrete purchase order issued under the company's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499.9...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $18,488.12 on August 12, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price delivery order, which is scheduled for completion by August 13, 2025, represents a task order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at $499.999 billion through November...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $18,436.85 by the Defense Logistics Agency's Medical Supply Chain division on July 23, 2025. This firm fixed-price delivery order, with an ultimate completion date of July 24, 2025, represents a specific instance of pharmaceutical supply fulfillment under the company's larger Indefinite Delivery Contract with the Defense Logistics Agency. The...
- SPE2DB22D9239Indefinite Delivery Contract
- SPE2DB22D9239-SPE2DB25FDL11Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $87,418.08 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xenpozyme 20 mg vials. This firm fixed-price delivery order, issued on August 13, 2025, with an ultimate completion date of September 4, 2025, represents a continuation of the companies' established partnership. The award was made without a set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the federal marketplace. Performance will occur at the company's Park Ridge, Illinois facility. This delivery order is issued under DMS Pharmaceutical Group's significant single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. The IDC enables the Defense Logistics Agency to issue firm fixed-price delivery orders for a comprehensive pharmaceutical supply portfolio supporting medical needs across Department of Defense healthcare facilities. As a established federal pharmaceutical supplier since 2001, DMS Pharmaceutical Group maintains a robust track record of delivering specialized pharmaceutical products, including oncology treatments and specialty medications, to military health facilities nationwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $87.4k | 8/13/25 |